secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scienture Holdings, Inc. (SCNX)
CIK:        0001382574
Form:       8-K
Filed at:   2023-03-27T23:59:59+00:00
Accession:  0001493152-23-009089
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRxADE HEALTH reports 16% revenue growth to $11.4M for FY2022; net loss narrows
-------------------------------------------------------------------------------

- Revenue $11.4M (+16% YoY); net loss narrowed to ($3.9M) from ($5.3M) in 2021.
- EPS ($0.41) per basic/diluted share vs ($0.65) prior year.
- Adjusted EBITDA improved to ($0.09M) from ($3.1M) in 2021.
- Added 1,212 new registered members; total ~14,400 on TRxADE platform.
- Trxade Prime revenue up 46% YoY; Community Specialty down 29%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382574/000149315223009089/0001493152-23-009089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382574/000149315223009089/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-009089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer